We are live on ! Find out more
MSOS icon

AdvisorShares Pure US Cannabis ETF

168 hedge funds and large institutions have $204M invested in AdvisorShares Pure US Cannabis ETF in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 48 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more call options, than puts

Call options by funds: $50.7M | Put options by funds: $46M

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

2% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 48

2.23% less ownership

Funds ownership: 41.73%39.51% (-2.2%)

7% less funds holding

Funds holding: 181168 (-13)

38% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 34

53% less capital invested

Capital invested by funds: $437M → $204M (-$233M)

Holders
168
Holders Change
-13
Holders Change %
-7.18%
% of All Funds
2.82%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
21
Increased
47
Reduced
48
Closed
34
Calls
$50.7M
Puts
$46M
Net Calls
+$4.7M
Net Calls Change
-$29.6M

MSOS Hedge Fund Activity: Q2 2022 in Review

168 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in AdvisorShares Pure US Cannabis ETF (MSOS) for Q2 2022, worth a combined $204M — down 53% from $437M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of MSOS and 21 opened new positions — a net loss of 13 holders — while 48 trimmed existing stakes and 47 added.

The largest buyer was Morgan Stanley, adding an estimated $16.9M. The largest seller was 140 Summer Partners, exiting entirely with an estimated $17.4M sold.

  • 168 institutional investors held AdvisorShares Pure US Cannabis ETF (MSOS) as of Q2 2022, down from 181 in Q1 2022.
  • Funds reported $204M of AdvisorShares Pure US Cannabis ETF stock for Q2 2022, down 53% quarter-over-quarter.
  • 21 funds opened new AdvisorShares Pure US Cannabis ETF positions in Q2 2022 and 34 closed out, a net change of -13 holders.
  • The largest AdvisorShares Pure US Cannabis ETF buyer in Q2 2022 was Morgan Stanley, an estimated $16.9M added.
  • The largest AdvisorShares Pure US Cannabis ETF seller in Q2 2022 was 140 Summer Partners, an estimated $17.4M sold.

Based on aggregated 13F filings for Q2 2022.